Our methodology considered multiple key AD-related genes (AChE, APP, BACE1, MAPT, PSEN1, TNF-α, and VCP) and their proteins, which is a significant advantage over previous studies that focused on a limited set of targets or employed simplistic scoring functions [26,27]. This evidence concerns the gene ACHE and Alzheimer disease.